2016
DOI: 10.7554/elife.19743
|View full text |Cite
|
Sign up to set email alerts
|

Large-scale remodeling of a repressed exon ribonucleoprotein to an exon definition complex active for splicing

Abstract: Polypyrimidine-tract binding protein PTBP1 can repress splicing during the exon definition phase of spliceosome assembly, but the assembly steps leading to an exon definition complex (EDC) and how PTBP1 might modulate them are not clear. We found that PTBP1 binding in the flanking introns allowed normal U2AF and U1 snRNP binding to the target exon splice sites but blocked U2 snRNP assembly in HeLa nuclear extract. Characterizing a purified PTBP1-repressed complex, as well as an active early complex and the fin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
21
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(25 citation statements)
references
References 115 publications
2
21
1
Order By: Relevance
“…This model contrasts with a previous proposal for sequential, intron-definitiontype interactions in the recognition of microexons (Sterner and Berget, 1993) and is also different from a more recent model invoking exon-enhancer-dependent interactions in the context of the extensively studied neuronal (N1) microexon of the Src gene (Wongpalee et al, 2016). This microexon is repressed in non-neural cells by Ptbp1-dependent interactions (Sharma et al, 2005), yet its mechanism of activation in neural cells has largely remained unclear (Wongpalee et al, 2016). We observe that knockdown of Srrm4, Srsf11, and Rnps1 all result in increased skipping of the N1 microexon ( Figure S4B).…”
Section: Discussioncontrasting
confidence: 89%
See 1 more Smart Citation
“…This model contrasts with a previous proposal for sequential, intron-definitiontype interactions in the recognition of microexons (Sterner and Berget, 1993) and is also different from a more recent model invoking exon-enhancer-dependent interactions in the context of the extensively studied neuronal (N1) microexon of the Src gene (Wongpalee et al, 2016). This microexon is repressed in non-neural cells by Ptbp1-dependent interactions (Sharma et al, 2005), yet its mechanism of activation in neural cells has largely remained unclear (Wongpalee et al, 2016). We observe that knockdown of Srrm4, Srsf11, and Rnps1 all result in increased skipping of the N1 microexon ( Figure S4B).…”
Section: Discussioncontrasting
confidence: 89%
“…In this model, the bi-partite ISE bound by Srsf11, Rnps1, and Srrm4 obviates the requirement for an exonic splicing enhancer (ESE) and thus enables the recognition of exons that are too short to harbor these elements or else may be subject to protein coding constraints that preclude the positioning of ESEs within exons. This model contrasts with a previous proposal for sequential, intron-definitiontype interactions in the recognition of microexons (Sterner and Berget, 1993) and is also different from a more recent model invoking exon-enhancer-dependent interactions in the context of the extensively studied neuronal (N1) microexon of the Src gene (Wongpalee et al, 2016). This microexon is repressed in non-neural cells by Ptbp1-dependent interactions (Sharma et al, 2005), yet its mechanism of activation in neural cells has largely remained unclear (Wongpalee et al, 2016).…”
Section: Discussionmentioning
confidence: 59%
“…PTBP1 is known to interact with hnRNP K (29), which binds directly to the viral M mRNA, as we previously reported (9). Since U1A binds U1 snRNA, which interacts with the 5′ splice site of pre-mRNAs to mediate the first steps of splicing (22), and PTBP1 represses the early stages of splicing (37), the NS1-BP BACK domain and hnRNP K likely interact with the PTBP1 complex to mediate or regulate the early stages of splicing. Furthermore, the Kelch domain of NS1-BP binds the Pol II CTD that interacts with the virus polymerase (33,34).…”
Section: Discussionmentioning
confidence: 70%
“…4h, Supplementary Fig. 7, and Supplementary Dataset 2) 7,17 . The effect of C3 peptide requires SF1 ( Supplementary Fig.…”
Section: Resultsmentioning
confidence: 99%